Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions ...
DGTR issues list of parties regarding bilateral safeguard probe on imports of DOTP, DEHCH from Korea
DGTR issues list of parties regarding bilateral safeguard probe on imports of DOTP, DEHCH from Korea: Shardul Nautiyal, Mumbai Saturday, November 22, 2025, 09:00 Hrs [IST] The Dir ...
Karnataka to invest Rs. 600-cr for deeptech; expected to fund AI-pharma as life sciences takes centre-stage: Nandita Vijayasimha, Bengaluru Saturday, November 22, 2025, 08:00 Hrs ...
NABL issues Guidance document for medical labs to ensure quality of test samples at collection centres: Shardul Nautiyal, Mumbai Saturday, November 22, 2025, 08:00 Hrs [IST] The N ...
Peethaambaran Kunnathoor, Chennai Saturday, November 22, 2025, 08:00 Hrs [IST] ...
DCGI directs state regulators to mandate display of PvPI's QR code in pharmacy premises: Gireesh Babu, New Delhi Saturday, November 22, 2025, 08:00 Hrs [IST] The Drugs Controller ...
CDSCO declares 211 drug samples as NSQs, five as spurious in October: Our Bureau, New Delhi Saturday, November 22, 2025, 08:00 Hrs [IST] The Central Drugs Standard Control Organis ...
Eris Lifesciences, PlexusMD join hands to offer AI powered online learning platform for doctors in India: Our Bureau, Mumbai Monday, July 1, 2019, 16:40 Hrs [IST] Eris Lifescience ...
Thermo Fisher Scientific Inc opens a state-of-the-art packaging and distribution facility in Ahmedabad to better serve pharmaceutical customer growth in India and their increasing need for clinical ...
Ingelheim, Germany Friday, November 21, 2025, 16:00 Hrs [IST] ...
US FDA approves Accord BioPharma’s denosumab biosimilars Osvyrti and Jubereq: Raleigh, North Carolina Friday, November 21, 2025, 18:00 Hrs [IST] Accord BioPharma, Inc., the spec ...
Amsterdam, the Netherlands Friday, November 21, 2025, 17:00 Hrs [IST] ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results